# Rhinovirus Study With Lactobacillus Rhamnosus GG

> **NCT01229917** · PHASE4 · COMPLETED · sponsor: **Valio Ltd**

## Conditions studied

- Respiratory Tract Infections [C08.730]

## Interventions

- **OTHER:** Fruit juice with Lactobacillus rhamnosus GG, version 1
- **OTHER:** Fruit juice with Lactobacillus rhamnosus GG, version 2
- **OTHER:** Standard fruit juice

## Key facts

- **NCT ID:** NCT01229917
- **Lead sponsor:** Valio Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-07-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01229917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01229917, "Rhinovirus Study With Lactobacillus Rhamnosus GG". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01229917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*